Results of treatment of two patients with MALT lymphoma
Open Access
- 30 July 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 10,p. 170-176
Abstract
Introduction. MALT lymphoma is a rare histological type of malignant lung disease that develops from lymphoid tissue. This type of lymphoma belongs to the non-Hodgkin lymphomas. Given the lack of a standardized treatment protocol for patients with pulmonary MALT lymphoma, this study presents a case observation of the treatment of this disease. Each case observation is crucial for establishing a unified treatment strategy.Aim. To demonstrate the effectiveness of comprehensive treatment in two patients with pulmonary MALT lymphoma.Methods. This study presents two clinical cases of successful treatment of patients with MALT lymphoma at the regional clinical oncological dispensary in Ulyanovsk. The authors present their observations and describe the treatment regimens used. One patient underwent a tumor biopsy, which was inconclusive. Given the non-specific clinical presentation and the CT findings of a mass in the right lung with an undetermined histogenesis, as well as mediastinal involvement, surgical intervention was indicated for the morphological diagnosis of the lung mass. In both cases, targeted support with Rituximab was included in the treatment regimen. One case involved five courses of R-B therapy without progression, while in the other case, targeted therapy is planned as the next step after polychemotherapy.Conclusions. MALT lymphoma is a rare nosological form. According to the authors, the most optimal treatment method is a combined approach, which includes surgical treatment, polychemotherapy, and subsequent targeted therapy.Keywords
This publication has 16 references indexed in Scilit:
- CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and non-pulmonary MALT lymphomaMethods, 2024
- Pulmonary extra‐nodal mucosa‐associated lymphoid tissue (MALT) lymphoma: A rare cause of persistent lung consolidationRespirology Case Reports, 2023
- Synchronous pulmonary MALT lymphoma and squamous cell lung cancer: a case reportWorld Journal of Surgical Oncology, 2023
- Diffuse Large B-Cell LymphomaNew England Journal of Medicine, 2021
- A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based reviewClinical Rheumatology, 2019
- Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trialBritish Journal of Haematology, 2019
- Dual institution experience of nodal marginal zone lymphoma reveals excellent long‐term outcomes in the rituximab eraBritish Journal of Haematology, 2016
- Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphomaJournal of Chemotherapy, 2014
- Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissueBlood, 2003
- Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphomaCancer, 1983